Benzinga - Wed, 21 Apr 2021 12:47:38 -0400
Benzinga - Thu, 25 Mar 2021 11:01:47 -0400
Benzinga - Thu, 25 Mar 2021 04:59:22 -0400
Benzinga - Wed, 24 Mar 2021 12:35:31 -0400
Benzinga - Wed, 24 Mar 2021 12:23:33 -0400
Benzinga - Wed, 24 Mar 2021 06:31:01 -0400
Benzinga - Wed, 24 Mar 2021 04:29:06 -0400
load more
Sector: Health Care.Industry: Biotechnology
Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-03
REV
Q4 2020Est.ActualSurprise
EPS-0.450-0.270 0.1800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CERECerevel Therapeutics Hldg-2.48%1.8B

Cerevel Therapeutics Hldg Company Questions & Answers

Q

How do I buy Cerevel Therapeutics Hldg (CERE) stock?

A

You can purchase shares of Cerevel Therapeutics Hldg (NASDAQ: CERE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cerevel Therapeutics Hldg's (CERE) main competitors?

A

Other companies in Cerevel Therapeutics Hldg’s space includes: Immunovant (NASDAQ:IMVT), Precigen (NASDAQ:PGEN) and Zentalis Pharmaceuticals (NASDAQ:ZNTL).

Q

What is the target price for Cerevel Therapeutics Hldg?

A

The latest price target for Cerevel Therapeutics Hldg (NASDAQ: CERE) was reported by Goldman Sachs on 2020-12-10. The analyst firm set a price target for 24.00 expecting CERE to rise to within 12 months (a possible 69.85% upside). 3 analyst firms have reported ratings in the last year.

Q

How much is Cerevel Therapeutics Hldg (CERE) stock ?

A

The stock price for Cerevel Therapeutics Hldg (NASDAQ: CERE) is $14.13 last updated Wed Apr 21 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Cerevel Therapeutics Hldg (CERE) dividend?

A

There are no upcoming dividends for Cerevel Therapeutics Hldg.

Q

When is Cerevel Therapeutics Hldg (NASDAQ:CERE) reporting earnings?

A
Cerevel Therapeutics Hldg’s Q1 earnings are confirmed after-market from now on May 3, 2021.
Q

When is the upcoming split for CERE?

A

There is no upcoming split for Cerevel Therapeutics Hldg.